1-3 of 3
F D Howard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overexpression of CD3 eta during thymic development does not alter the negative selection process.

R E Hussey, L K Clayton, A Diener, D J McConkey, F D Howard, H R Rodewald, L D'Adamio, F Dallenbach, H Stein, E V Schmidt
Journal: The Journal of Immunology
J Immunol (1993) 150 (4): 1183–1194.
https://doi.org/10.4049/jimmunol.150.4.1183
Published: 15 February 1993
View article titled, Overexpression of CD3 eta during thymic development does not alter the negative selection process.
Open the PDF for Overexpression of CD3 eta during thymic development does not alter the negative selection process. in another window
Add to Citation Manager
Journal Articles

A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation.

F D Howard, J A Ledbetter, J Wong, C P Bieber, E B Stinson, L A Herzenberg
Journal: The Journal of Immunology
J Immunol (1981) 126 (6): 2117–2122.
https://doi.org/10.4049/jimmunol.126.6.2117
Published: 01 June 1981
View article titled, A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation.
Open the PDF for A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation. in another window
Add to Citation Manager
Journal Articles

An in vitro line of the B cell tumor BCL1 can be activated by LPS to secrete IgM1.

E S Gronowicz, C A Doss, F D Howard, D C Morrison, S Strober
Journal: The Journal of Immunology
J Immunol (1980) 125 (3): 976–980.
https://doi.org/10.4049/jimmunol.125.3.976
Published: 01 September 1980
View article titled, An in vitro line of the B cell tumor BCL1 can be activated by LPS to secrete IgM1.
Open the PDF for An in vitro line of the B cell tumor BCL1 can be activated by LPS to secrete IgM1. in another window
Add to Citation Manager